Prot# A3921030: A Phase 2 Randomized. Multicenter, Active Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Coadministration of CP-690,550 and Mycophenolate Mofetil/Mycophenolate Sodium in De Novo Kidney Allograft Recipients

Project: Research project

Project Details

StatusFinished
Effective start/end date12/5/07 → 12/5/10

Funding

  • ICON Clinical Research, LLC (A3921030 // A3921030)
  • Pfizer Inc. (A3921030 // A3921030)